Proactive - Interviews for investors
Crucial Innovations CEO JP Doran on unique proposition and growth strategy
Crucial Innovations Corp CEO Jon-Paul Doran talked with Proactive's Stephen Gunnion about the company’s expansion. The US-based firm, soon to be quoted on the OTC markets, operates a vertically integrated business with cultivation facilities in South Africa and a dispensary in the UK.
Doran highlighted the company’s seed-to-sale model, which ensures control over quality and supply. He explained that their proprietary genetics provide an edge in the medicinal market, enabling precision medicine for patients. With a low-cost production base in South Africa and a growing European and UK market focus, the company is positioned for long-term growth.
Discussing the decision to list in the US, Doran cited higher investor interest and market potential compared to the UK. He expects Crucial Innovations to start trading on the OTCQB by mid-to-late April, with a plan to uplist to the OTCQX and eventually Nasdaq.
The company also has an aggressive acquisition strategy, aiming to acquire high-efficiency operators to boost its net asset value, revenue, and human capital. “We want to be a driver of consistent quality,” Doran emphasized, highlighting South Africa’s progressive stance and the expertise of its cultivation specialists.
Watch the full interview to learn more about Crucial Innovations’ vision and upcoming milestones. Don't forget to like, subscribe, and turn on notifications for more updates from Proactive!
#CrucialInnovations #OTCMarkets #Investing #CannabisIndustry #JPdoran #SouthAfrica #SeedToSale #OTCQB #OTCQX #Nasdaq #ProactiveInvestors